News Release

Assessment of lupus anticoagulant positivity in patients with COVID-19

Peer-Reviewed Publication

JAMA Network

What The Study Did: How common lupus anticoagulant (LA) positivity is in patients with COVID-19 was assessed in this observational study, which also examined the association of LA positivity with patient outcomes.

Authors: Morayma Reyes Gil, M.D., Ph.D., of Montefiore Medical Center in New York, is the corresponding author.

To access the embargoed study: Visit our For The Media website at this link


Editor's Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.


Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time

About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.